Alpha Growth plc
("Alpha" or the "Company")
Exercise of Warrants, Issue of Equity for Expenses, and Total Voting Rights
Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services specialist in the growing longevity asset class and insurance linked asset management, announces that it has received warrant exercise notices over an aggregate total of 18,750,000 ordinary shares of 0.1p each ("Ordinary Shares") in the Company for total consideration of £375,000.
In addition, the Company has issued 1,176,143 Ordinary Shares to certain advisers in lieu of expenses owed to them in relation to the Company's insurance business in 2022 at the closing price of 2.45p per Ordinary Share on 31 December 2022.
Application has been made for a total of 19,926,143 Ordinary Shares to be admitted to the standard listing segment of the Official List of the Financial Conduct Authority and to be admitted to trading on the main market for listed securities of the London Stock Exchange plc (together, "Admission"). Admission is expected to become effective at 8.00 a.m. on 20 March 2023.
Total Voting Rights
On Admission, the Company's issued share capital will consist of 451,813,531 Ordinary Shares. There are no Ordinary Shares held in treasury. Accordingly, the total number of voting rights in Alpha Growth plc at Admission will be 451,813,531.
The above figure 451,813,531 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Alpha Growth plc under the FCA's Disclosure Guidance and Transparency Rules.
** ENDS **
For more information, please visit www.algwplc.com or contact the following:
| Alpha Growth plc | +44 (0) 20 3959 8600 |
| Gobind Sahney, Executive Chairman | |
|
Allenby Capital Limited | +44 (0) 20 3328 5656 |
| Amrit Nahal (Sales and Corporate Broking) | |
| Nick Athanas / Piers Shimwell (Corporate Finance) | |
|
UK Investor Relations - Mark Treharne |
About Alpha Growth plc
Specialist in Longevity Assets
Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.
Longevity Assets and Non-correlation
As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.
Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.
Forward Looking Statements Disclaimer
Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward- looking statements, which speak only as of the date of this document. Readers should not treat the contents of this document as advice relating to legal, taxation or investment matters, and are to make their own assessments concerning these and other consequences, including the merits of information and the risks. Readers of this announcement are advised to conduct their own due diligence and agree to be bound by the limitations of this disclaimer.
Important Notice
The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.